Back to Search Start Over

Synergistic Antitumor Activity of Gramicidin/Lipophilic Bismuth Nanoparticles (BisBAL NPs) on Human Cervical Tumor Cells

Authors :
Claudio Cabral-Romero
Yesennia Sánchez-Pérez
Nayely Pineda-Aguilar
Irene Meester
Shankararaman Chellam
Claudia M. García-Cuellar
Juan Manuel Solis-Soto
Rene Hernandez-Delgadillo
Source :
Frontiers in Nanotechnology, Vol 3 (2021)
Publication Year :
2021
Publisher :
Frontiers Media SA, 2021.

Abstract

The objective of this study was to study the synergistic antitumor effect of lipophilic bismuth nanoparticles (BisBAL NPs) with the antibiotic solution Neo-Poly gramicidin on human cervical tumor cells. The effect of BisBAL NPs and Neo-Poly gramicidin solution on cervical cancer cell line (HeLa) was determined by the MTT cell viability assay and fluorescence microscopy. After a 24-h exposure to 0.1× Neo-Poly gramicidin HeLa cell growth decreased 94%. Fluorescence microscopy confirmed the antitumor effect cell death was higher among treated than among non-treated cells cells. Individually, gramicidin (0.04 mg/mL) inhibited HeLa tumor cell growth most (40%), and neomycin (0.04 mg/mL) least (21%). Gramicidin (0.3 mg/mL) in combination with different concentrations (1–150 μM) of BisBAL NPs had a synergistic antitumor effect against HeLa cells, reaching an < 86% tumor growth inhibition. As far as we know, we are the first to describe the antitumor activity of the antibiotic Neo-Poly gramicidin on a human cervical cancer cell line. The action mechanism of gramicidin/BisBAL NP is based on a strong damage on cell membrane and nucleus of tumor cells. A synergistic effect of gramicidin with BisBAL NPs may be useful as an alternative therapy for cervical cancer patients.

Details

ISSN :
26733013
Volume :
3
Database :
OpenAIRE
Journal :
Frontiers in Nanotechnology
Accession number :
edsair.doi.dedup.....104bb2865e442336d7e0dbec3a51b008
Full Text :
https://doi.org/10.3389/fnano.2021.633604